Castagna A - Search Results

1

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses.

Ramirez GA, Ripa M, Burastero S, Benanti G, Bagnasco D, Nannipieri S, Monardo R, Ponta G, Asperti C, Cilona MB, Castagna A, Dagna L, Yacoub MR. Ramirez GA, et al. Among authors: castagna a. Microorganisms. 2023 Jan 30;11(2):346. doi: 10.3390/microorganisms11020346. Microorganisms. 2023. PMID: 36838310 Free PMC article. Review.

2

Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection.

Nozza S, Bigoloni A, Calcagno A, Galli L, Pignataro AR, D'Avolio A, Carbone A, Ripa M, Bonora S, Lazzarin A, Castagna A. Nozza S, et al. Among authors: castagna a. J Antimicrob Chemother. 2014 May;69(5):1436-9. doi: 10.1093/jac/dkt530. Epub 2014 Jan 23. J Antimicrob Chemother. 2014. PMID: 24458511 No abstract available.

3

Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine.

Nozza S, Galli L, Bigoloni A, Gianotti N, Spagnuolo V, Carbone A, Chiappetta S, Ripa M, Tambussi G, Lazzarin A, Castagna A. Nozza S, et al. Among authors: castagna a. New Microbiol. 2014 Apr;37(2):145-51. Epub 2014 Apr 1. New Microbiol. 2014. PMID: 24858641 Free article. Clinical Trial.

4

Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir.

Gianotti N, Galli L, Poli A, Salpietro S, Nozza S, Carbone A, Merli M, Ripa M, Lazzarin A, Castagna A. Gianotti N, et al. Among authors: castagna a. Medicine (Baltimore). 2016 May;95(22):e3780. doi: 10.1097/MD.0000000000003780. Medicine (Baltimore). 2016. PMID: 27258510 Free PMC article.

5

48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study.

Nozza S, Pignataro AR, Galli L, Svicher V, Alteri C, Boeri E, Ripa M, Castagna A, Sampaolo M, Clementi M, Perno CF, Lazzarin A. Nozza S, et al. Among authors: castagna a. New Microbiol. 2016 Jul;39(3):192-196. New Microbiol. 2016. PMID: 27704143 Free article. Clinical Trial.

6

Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.

Nozza S, Poli A, Ripa M, Galli L, Chiappetta S, Spagnuolo V, Rovelli C, Lazzarin A, Castagna A, Tambussi G. Nozza S, et al. Among authors: castagna a. J Antimicrob Chemother. 2017 Feb;72(2):632-633. doi: 10.1093/jac/dkw439. Epub 2016 Oct 17. J Antimicrob Chemother. 2017. PMID: 27798217 No abstract available.

7

Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response.

Nozza S, Poli A, Ripa M, Galli L, Chiappetta S, Spagnuolo V, Rovelli C, Lazzarin A, Castagna A, Tambussi G. Nozza S, et al. Among authors: castagna a. J Antimicrob Chemother. 2017 May 1;72(5):1549-1550. doi: 10.1093/jac/dkx073. J Antimicrob Chemother. 2017. PMID: 28333303 No abstract available.

8

Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients.

Gianotti N, Poli A, Nozza S, Galli L, Galizzi N, Ripa M, Merli M, Carbone A, Spagnuolo V, Lazzarin A, Castagna A. Gianotti N, et al. Among authors: castagna a. BMC Infect Dis. 2017 Nov 16;17(1):723. doi: 10.1186/s12879-017-2831-9. BMC Infect Dis. 2017. PMID: 29145807 Free PMC article.

9

Eosinophils from Physiology to Disease: A Comprehensive Review.

Ramirez GA, Yacoub MR, Ripa M, Mannina D, Cariddi A, Saporiti N, Ciceri F, Castagna A, Colombo G, Dagna L. Ramirez GA, et al. Among authors: castagna a. Biomed Res Int. 2018 Jan 28;2018:9095275. doi: 10.1155/2018/9095275. eCollection 2018. Biomed Res Int. 2018. PMID: 29619379 Free PMC article. Review.

10

Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen.

Gianotti N, Galli L, Galizzi N, Ripa M, Andolina A, Nozza S, Spagnuolo V, Poli A, Lazzarin A, Castagna A. Gianotti N, et al. Among authors: castagna a. Int J Antimicrob Agents. 2018 Oct;52(4):492-499. doi: 10.1016/j.ijantimicag.2018.07.001. Epub 2018 Sep 13. Int J Antimicrob Agents. 2018. PMID: 30009958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,088 results

Search Page